The UW LEAP study partnered with Pongo, a local nonprofit writers’ group, to bring the healing properties of poetry to individuals with the lived experience of homelessness and alcohol use problems. Writing mentors worked with residents between September 17th-November 12th to create meaningful poetry around topics such as love, loss, alcohol and baseball. On November 18th, a poetry reading evening was held for people to share their work with the community. It was a joyous occasion!
An article published in Real Change covers our work with the Life Enhancing Alcohol-management Program (LEAP) and the art collective. Read article
“Meeting People Where They’re At: Community-based Harm Reduction Treatment for Alcohol Use Disorders”
Dr. Susan Collins was selected as one of three New Investigators to be featured in the University of Washington School of Medicine’s Science in Medicine lecture series and will be representing the HaRRT lab’s awesome work!
Date: Wednesday, November 4, 2015
Time: 1:00 – 2:00 PM
Location: HSB D-209, Turner Auditorium
UW Health Sciences Center (D-wing)
“Meeting People Where They’re At: Community-based Harm Reduction Treatment for Alcohol Use Disorders”
Friday Noon Conference is held in the Harborview R&T building #109 from 12-1 (NE corner of 9th Ave & Alder, ground level), where lunch will be served. As always, we ask everyone to do their best to be seated on time.
Dr. Collins is a licensed clinical psychologist and Associate Professor at the University of Washington – Harborview Medical Center. She has been involved in substance use research for nearly two decades and has disseminated this work in over 60 book chapters, abstracts and peer-reviewed articles. Together with her colleague, Dr. Seema Clifasefi, she codirects the Harm Reduction Research and Treatment Lab. In the HaRRT lab, she works with a multidisciplinary research and clinical team, community-based agencies, traditional Native healers, and substance-using community members to co-develop and evaluate interventions that aim to reduce substance-related harm and improve quality of life for affected individuals and their communities. Dr. Collins is an awardee of the G. Alan Marlatt Memorial Research Award for her contributions to alcohol research and was recently nominated as one of three New Investigators in the University of Washington Science in Medicine lecture series.
In early July 2015, Drs. Clifasefi and Collins went to the White House to share with President Obama’s senior policy advisers and delegates from across the county their program evaluation on a harm-reduction approach to criminal justice: the Law Enforcement Assisted Diversion Program (LEAD). Read their two reports showing how LEAD decreases criminal recidivism as well as criminal justice and legal system utilization and associated costs here. Read press on this here.
An article was published by the Seattle Times on the impact of Seattle’s Law Enforcement Assisted Diversion (LEAD) program. Read about it here!
Also see:
We have posted this new position (30-35% FTE, temporary position) for our NIH-funded patient-driven, harm-reduction, pharmacobehavioral treatment study. we are looking for an RN who has at least a bachelor-level training, research experience (particularly with diverse and AI/AN communities), experience with long-acting injectables, and a harm-reduction or motivational interviewing background and approach. We value diversity and are committed to creating and maintaining an environment that respects diverse identities, traditions, heritages, and experiences.
The position is listed on the University of Washington hires website. Check it out! Req #117068
An article published in Newsweek mentioned our work with naltrexone (Vivitrol) and how it can help participants take a step closer towards moderation. Check it out!
An article published in The TYEE covers our work with the Law Enforcement Assisted Diversion (LEAD) program. Read the article here.